Position in ACRS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,551,857
+$679,529 QoQ
Shares Held
947,162
-0.7% QoQ
Ownership
0.678%
of shares outstanding
% of Portfolio
3.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Aldebaran Capital, LLC holds $6,628,340 across 7 Biotechnology names. ACRS ranks #1 (53.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACRS |
Aclaris Therapeutics, Inc.
This page
|
947,162 | $3,551,857 | |
| 2 | TECX |
Tectonic Therapeutic, Inc.
|
37,184 | $1,149,357 | |
| 3 | KZR |
Kezar Life Sciences, Inc.
|
80,335 | $596,085 | |
| 4 | PMVP |
PMV Pharmaceuticals, Inc.
|
473,362 | $586,968 | |
| 5 | AVIR |
Atea Pharmaceuticals, Inc.
|
89,946 | $483,909 | |
| 6 | OKUR |
OnKure Therapeutics, Inc.
|
40,419 | $167,334 | |
| 7 | IMA |
ImageneBio, Inc.
|
18,566 | $92,830 |
All Filings in ACRS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,551,857 | 947,162 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,872,328 | 954,262 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,876,626 | 987,698 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,411,051 | 993,698 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,542,175 | 1,007,958 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,522,055 | 1,016,958 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,199,624 | 1,043,152 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $943,967 | 858,152 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||